At the request of NACDS and the New York State Pharmacy Coalition, the New York State Department of Health issued the New York State Opioid Annual Assessment Reporting Guidance for pharmacies about how to manage any obligations for opioids that are stored in intracompany distribution centers in the state under the newly created opioid assessment program that was established by the enactment of the Opioid Stewardship Act. The guidance was effective July 1 and reporting requirements are effective on Wednesday, August 1.
Also in New York…This week, Gov. Andrew Cuomo (D) signed S9100, The Drug Take Back Act, into law. The newly enacted law requires certain drug manufacturers to fund a statewide drug take back program to be implemented by pharmacies operating in 10 or more locations. It takes effect in 180 days and 180 days from then the manufacturers are required to submit their drug take back plans to the New York State Department of Health (DOH) for approval. Also, DOH is authorized to begin to develop regulations and other work around implementation prior to the effective date.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.